DRAFT Clinical Practice Guidelines for Deprescribing in Older People
Make a submissionThank you for your interest in participating in the public consultation.
We are developing clinical practice guidelines to provide healthcare professionals with guidance for deprescribing medicines. The guideline states recommendations that are intended to be used within a shared decision-making framework, rather than prescriptive mandates.
We are now seeking your feedback on the DRAFT Guidelines. Your input is highly valued and will help shape the final version.
The full Participant Information Sheet and Consent Form is available within the submission form .
Who can make a submission?
Anyone with an interest in deprescribing is invited to make a submission. This includes:
- Consumers/carers/family members with lived or living experience
- Individuals with an interest
- Consumer advocates
- Healthcare professionals
- Researchers/ academics
- Health policymakers/ service providers
- Any members of the public
Submissions can be made by individuals or on behalf of an organisation.
How do I make a submission?
Submissions can be made online via this online form (If the link does not open, please copy and paste the following link into your browser: https://uwa.qualtrics.com/jfe/form/SV_3l3eObHpqhna8lM).
The form will automatically save your progress. If you need to return later, please use the same device and browser to access your previous responses.
Submissions close Saturday, 31st May 2025 (11:59 pm AEST). Late submissions will not be accepted.
What questions will be asked?
The submission form includes both general and specific questions about the DRAFT Guidelines. You are not required to respond to every question – please focus on areas that are most relevant or important to you.
You may wish to consider:
- Is the guideline clear and easy to follow? If not, which sections need improvement?
- Are there any terms or concepts that require further clarification?
- Does the guideline address key concerns relevant to your role or experience?
- Is there sufficient detail to support decision-making for deprescribing? What additional information would be helpful?
- How do you envision this guideline being used in practice?
Why your views matter
Your input will play a crucial role in refining the final version of the guidelines. All feedback will be carefully reviewed and considered. A report of public consultation will be published alongside the final guideline for transparency. Your responses will remain confidential, and your identity will not be linked to any of the feedback you provide unless you provide consent.
Ethics approval
Ethics approval has been granted by the University of Western Australia Human Research Ethics Committee (Ref: 2023/ET001118).
Contacts
If you experience any issues accessing any documents, please email us and we will provide them in an alternate format.
📩 General enquiries: deprescribing@uwa.edu.au
Please note: Feedback on the draft guidelines must be submitted via the online form and will not be accepted via email.
Public Consultation Materials
The following draft documents are available for download:
DRAFT Technical Report
Describes the methodology used in the development of the deprescribing guidelines, including evidence review and recommendation formulation process.
Download
DRAFT Administrative Report
Documents the non-technical aspects of guideline development, including information on the governance structure, funding sources, development timelines, stakeholder involvement, and the processes used to declare and manage conflicts of interest.
Download
DRAFT Dissemination and Implementation Plan
Outlines proposed strategies for disseminating and implementing the guideline in practice.
Download